Publication Precigen ActoBio’s Phase 1b/2a clinical trial results in Diabetologia journal

Publication Precigen ActoBio’s Phase 1b/2a clinical trial results in Diabetologia journal

Congratulations to Precigen Actobio for the publication of their Phase 1b/2a clinical trial results with AG019 in recent onset Type 1 diabetes in the Diabetologia journal

 

Curious about the article? Check here

 

Emtex’ contribution to this publication included:

 

– drafting of the manuscript based on source documents and implementing review comments of the authors,

– formatting figures and tables according to the journal’s guidelines,

– aligning the manuscript with the CONSORT checklist, and

– final editing and preparing for submission.

 

Are you also looking for medical writing support to successfully publish your scientific article? Do not hesitate to contact us!

Customer testimonial:

 

“Emtex Life Science has been a trustworthy partner for us in terms of medical writing activities during the past years of excessive growth of our company and the resulting high work pressure. We are looking forward to continue our pleasant yet professional collaboration with Emtex Life Science.”

CEO